Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Netherlands Journal of Medicine|April 1, 1989
Clinical relevance of lysozyme in the faecesM H Hemrika, G M Costongs, L G Engels, et al.
The Netherlands Journal of Medicine|August 1, 1989
Sucralphate-technetium scintigraphy in inflammatory bowel disease: experience in 23 patientsR N Zeijen, H A van der Pol, G J Teule, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 19, 2003
[A patient with biliary papillomatosis, a rare condition of the biliary system, with fatal outcome]M C van Kouwen, J P Drenth, L G Engels, et al.
European Journal of Gastroenterology & Hepatology|May 19, 1998
Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factorsM G Russel, L G Engels, J W Muris, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 14, 1987
Faecal lysozyme: determination, reference intervals and some data in gastro-intestinal diseaseG M Costongs, M H Hemrika, L G Engels, et al.
Gut|April 1, 1994
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferationF J Kubben, A Peeters-Haesevoets, L G Engels, et al.
Digestive Diseases and Sciences|November 26, 1999
Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomasT M de Kok, A van Faassen, B Glinghammar, et al.
Alimentary Pharmacology & Therapeutics|November 3, 1998
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study GroupH J Van Hoogstraten, M B De Smet, W Renooij, et al.
Pageof 2